Human identification using a panel of snps
AssigneeLife Technologies Corporation
InventorRobert LAGACE
Life of this patent
Estimating the term…
Abstract
The present invention provides methods, compositions, kits, systems and apparatus that are useful for multiplex PCR of one or more nucleic acids which belong to a panel of single nucleotide polymorphisms (SNPs) useful to identify a human. In particular, various target-specific primers are provided that allow for the selective amplification of one or more target sequences in the panel. In some aspects, amplified target sequences obtained using the disclosed methods, kits, systems and apparatuses can be used in various downstream processes including nucleic acid sequencing and used to identify a human.
Claims16
A method comprising:
- a) amplifying a plurality of different target sequences within a sample comprising:
- b) amplifying within a single amplification reaction mixture a plurality of different target sequences wherein the target sequences are a panel of at least fifty single nucleotide polymorphism (SNP) regions selected from Table A, wherein the amplifying includes contacting at least some portion of the sample with a plurality of target-specific primers and a polymerase under amplification conditions, thereby producing an amplified plurality of target sequences wherein at least two of the different amplified target sequences are less than 50% complementary to each other and wherein at least one of the plurality of amplified target sequences includes a cleavable group, wherein the cleavable group is uracil;
- c) cleaving a cleavable group of at least one amplified target sequence of the amplified plurality of target sequences;
- d) ligating at least one adapter to at least one amplified target sequence in a blunt-ended ligation reaction, thereby producing one or more adapter-ligated amplified target sequences, and
- e) reamplifying at least one of the adapter-ligated amplified target sequences, wherein at least one target-specific primer is substantially complementary to at least a portion of a corresponding target sequence in the sample.
Dependencies are inferred from the claim text.